COVID-19 in Kidney Transplant Recipients Vaccinated With Oxford-AstraZeneca COVID-19 Vaccine (Covishield): A Single-center Experience From India.
作者信息
Meshram Hari Shankar, Kute Vivek B, Shah Nauka, Chauhan Sanshriti, Navadiya Vijay V, Patel Ansy H, Patel Himanshu V, Engineer Divyesh, Banerjee Subho, Rizvi Jamal, Mishra Vineet V
机构信息
Department of Nephrology and Transplantation Sciences, Institute of Kidney Diseases and Research Center, Dr HL Trivedi Institute of Transplantation Sciences (IKDRC-ITS), Ahmedabad, Gujarat, India.
Department of Medicine, BJ Medical College, Ahmedabad, Gujarat, India.
出版信息
Transplantation. 2021 Sep 1;105(9):e100-e103. doi: 10.1097/TP.0000000000003835.
Abstract
摘要
相似文献
1
COVID-19 in Kidney Transplant Recipients Vaccinated With Oxford-AstraZeneca COVID-19 Vaccine (Covishield): A Single-center Experience From India.接种牛津-阿斯利康新冠疫苗（Covishield）的肾移植受者中的COVID-19：来自印度的单中心经验。
Transplantation. 2021 Sep 1;105(9):e100-e103. doi: 10.1097/TP.0000000000003835.
2
Kidney transplant recipients vaccinated before transplantation maintain superior humoral response to SARS-CoV-2 vaccine.移植前接种疫苗的肾移植受者对 SARS-CoV-2 疫苗保持优越的体液反应。
Clin Transplant. 2021 Dec;35(12):e14478. doi: 10.1111/ctr.14478. Epub 2021 Sep 29.
3
Differences in clinical outcomes of COVID-19 among vaccinated and unvaccinated kidney transplant recipients.接种疫苗和未接种疫苗的肾移植受者 COVID-19 临床结局的差异。
Vaccine. 2022 May 26;40(24):3313-3319. doi: 10.1016/j.vaccine.2022.04.066. Epub 2022 Apr 27.
4
Serological response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients depends on prior exposure to SARS-CoV-2.肾移植受者对新型冠状病毒mRNA疫苗BNT162b2的血清学反应取决于既往对新型冠状病毒的接触情况。
Am J Transplant. 2021 Nov;21(11):3806-3807. doi: 10.1111/ajt.16726. Epub 2021 Jul 10.
5
Protection against SARS-CoV-2 Variants with COVID-19 Vaccination in Kidney Transplant Recipients.肾移植受者接种新冠疫苗对SARS-CoV-2变异株的防护作用
Clin J Am Soc Nephrol. 2022 Jan;17(1):3-5. doi: 10.2215/CJN.14881121. Epub 2021 Dec 22.
6
A fourth SARS-CoV-2 mRNA vaccine in strictly seronegative kidney transplant recipients.严格血清阴性肾移植受者中的第四种SARS-CoV-2 mRNA疫苗。
Kidney Int. 2022 Apr;101(4):825-826. doi: 10.1016/j.kint.2022.01.017. Epub 2022 Feb 12.
7
SARS-CoV-2 Infection After Vaccination: Kidney Transplant Recipient Profile and Disease Evolution in a Single Center.接种疫苗后感染 SARS-CoV-2：单中心的肾移植受者特征和疾病演变。
Transplant Proc. 2022 Jul-Aug;54(6):1476-1482. doi: 10.1016/j.transproceed.2021.12.013. Epub 2022 Jan 7.
8
Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients.肾移植受者首次接种mRNA新冠疫苗后抗SARS-CoV-2抗体反应较弱。
Kidney Int. 2021 Jun;99(6):1487-1489. doi: 10.1016/j.kint.2021.03.014. Epub 2021 Mar 26.
9
Kidney transplant recipients' attitudes toward COVID-19 vaccination and barriers and enablers to vaccine acceptance.肾移植受者对 COVID-19 疫苗接种的态度以及对疫苗接种的接受的障碍和促进因素。
Transpl Infect Dis. 2022 Feb;24(1):e13749. doi: 10.1111/tid.13749. Epub 2021 Nov 3.
10
Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients.肾移植受者对第三剂SARS-CoV-2 mRNA BNT162b2疫苗的抗体和T细胞反应。
Kidney Int. 2021 Dec;100(6):1337-1340. doi: 10.1016/j.kint.2021.09.014. Epub 2021 Oct 4.
引用本文的文献
1
A Retrospective and Comparative Analysis of Clinical Outcomes of Kidney Transplant Recipients During First and Second COVID-19 Waves in North-West India.印度西北部肾移植受者在第一波和第二波新冠疫情期间临床结局的回顾性比较分析
Cureus. 2024 Jan 5;16(1):e51693. doi: 10.7759/cureus.51693. eCollection 2024 Jan.
2
COVID-19 Breakthrough Infections in Vaccinated Kidney Transplant Recipients.接种疫苗的肾移植受者中的新冠病毒突破性感染
Vaccines (Basel). 2022 Nov 11;10(11):1911. doi: 10.3390/vaccines10111911.
3
Seroconversion Rate After SARS-CoV-2 Infection and Two Doses of Either ChAdOx1-nCOV COVISHIELD™ or BBV-152 COVAXIN™ Vaccination in Renal Allograft Recipients: An Experience of Two Public and Private Tertiary Care Center.肾移植受者感染新型冠状病毒2后以及接种两剂ChAdOx1-nCOV COVISHIELD™或BBV-152 COVAXIN™疫苗后的血清转化率：两家公立和私立三级医疗中心的经验
Front Immunol. 2022 Jun 30;13:911738. doi: 10.3389/fimmu.2022.911738. eCollection 2022.
4
Benefits of Inactivated Vaccine and Viral Vector Vaccine Immunization on COVID-19 Infection in Kidney Transplant Recipients.灭活疫苗和病毒载体疫苗免疫对肾移植受者新型冠状病毒肺炎感染的益处
Vaccines (Basel). 2022 Apr 8;10(4):572. doi: 10.3390/vaccines10040572.
5
COVID-19 Vaccines in Pancreatic Transplant Recipients: A Single-Center Observative Study.新型冠状病毒肺炎疫苗在胰腺移植受者中的应用：一项单中心观察性研究。
Transplant Proc. 2022 May;54(4):925-929. doi: 10.1016/j.transproceed.2022.03.002. Epub 2022 Mar 15.
6
Anti-SARS-CoV-2 Antibody Level among Renal Transplant Recipients: A Case Report from Nepal.肾移植受者中的抗SARS-CoV-2抗体水平：来自尼泊尔的一例报告
Case Rep Urol. 2022 Jan 10;2022:2889501. doi: 10.1155/2022/2889501. eCollection 2022.
7
Mucormycosis as SARS-CoV2 sequelae in kidney transplant recipients: a single-center experience from India.肾移植受者继发于 SARS-CoV2 的毛霉菌病：来自印度的单中心经验。
Int Urol Nephrol. 2022 Jul;54(7):1693-1703. doi: 10.1007/s11255-021-03057-5. Epub 2021 Nov 18.
8
SARS-CoV-2-specific humoral and cell-mediated immune responses after immunization with inactivated COVID-19 vaccine in kidney transplant recipients (CVIM 1 study).肾移植受者接种新冠灭活疫苗后针对 SARS-CoV-2 的体液和细胞免疫应答（CVIM 1 研究）。
Am J Transplant. 2022 Mar;22(3):813-822. doi: 10.1111/ajt.16867. Epub 2021 Dec 6.
9
Consequences of the first and second COVID-19 wave on kidney transplant recipients at a large Indian transplant centre.第一波和第二波 COVID-19 疫情对印度某大型移植中心肾移植受者的影响。
Nephrology (Carlton). 2022 Feb;27(2):195-207. doi: 10.1111/nep.13961. Epub 2021 Aug 21.
10
Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD.慢性肾脏病患者对SARS-CoV-2疫苗接种的早期免疫反应综述
Kidney Int Rep. 2021 Sep;6(9):2292-2304. doi: 10.1016/j.ekir.2021.06.027. Epub 2021 Jul 6.
Zotero 插件